Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 6—June 2003
Research

Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001

Kevin S. Griffith*†Comments to Author , Paul S. Mead*, Gregory L. Armstrong*, John A. Painter*, Katherine A. Kelley†, Alex R. Hoffmaster*, Donald Mayo†, Diane Barden†, Renee Ridzon*, Umesh D. Parashar*, Eyasu Habtu Teshale*, Jen Williams*, Stephanie Noviello*‡, Joseph F. Perz*, Eric E. Mast*, David L. Swerdlow*, and James L. Hadler†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Connecticut Department of Public Health, Hartford, Connecticut, USA; ‡New York State Department of Health, Albany, New York, USA

Main Article

Figure 1

Bioterrorism-related inhalational anthrax cases by week of symptom onset—United States, 2001.The first two cases of inhalational anthrax occurred in Florida. Though no direct exposure source was found, environmental samples of the media company in which these two patients worked and the postal facilities serving the media company yielded Bacillus anthracis spores specifically implicating a B. anthracis–containing letter or package (4): †, the letters to Senators Thomas Daschle and Patraick Leahy

Figure 1. Bioterrorism-related inhalational anthrax cases by week of symptom onset—United States, 2001.The first two cases of inhalational anthrax occurred in Florida. Though no direct exposure source was found, environmental samples of the media company in which these two patients worked and the postal facilities serving the media company yielded Bacillus anthracis spores specifically implicating a B. anthracis–containing letter or package (4): †, the letters to Senators Thomas Daschle and Patraick Leahy were postmarked in the Trenton, New Jersey, processing and distribution center on October 9, 2001; black bars indicate cases of inhalational anthrax in persons with direct exposure to a B. anthracis–containing letter; gray bars indicate cases of inhalational anthrax persons with no known B. anthracis exposure.

Main Article

References
  1. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep. 2001;50:941–8.PubMedGoogle Scholar
  2. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalational anthrax—Connecticut, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1049–51.PubMedGoogle Scholar
  3. Barakat  LA, Quentzel  HL, Jernigan  JA, Kirschke  DL, Griffith  K, Spear  SM, Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA. 2002;287:863–8. DOIPubMedGoogle Scholar
  4. Jernigan  J, Stephens  D, Ashford  D, Omenaca  C, Topiel  MS, Galbraith  M, Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933–44. DOIPubMedGoogle Scholar
  5. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep. 2001;50:909–19.PubMedGoogle Scholar
  6. Centers for Disease Control and Prevention. Epidemiologic notes and reports: anthrax—Connecticut. MMWR Morb Mortal Wkly Rep. 1968;17:102.
  7. Keim  P, Price  L, Klevytska  A, Smith  KL, Schupp  JM, Okinaka  R, Multiple-locus variable-number tandem repeat analysis reveals genetic relationships with Bacillus anthracis. J Bacteriol. 2000;182:2928–36. DOIPubMedGoogle Scholar
  8. Hoffmaster  AR, Fitzgerald  CC, Ribot  E, Mayer  LW, Popovic  T. Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis. 2002;8:1111–6.PubMedGoogle Scholar
  9. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax—Connecticut, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1077–9.PubMedGoogle Scholar
  10. Williams  AA, Parashar  UD, Stoica  A, Ridzon  R, Kirschke  DL, Meyer  RF, Bioterrorism-related anthrax surveillance, Connecticut, September–December, 2001. Emerg Infect Dis. 2002;8:1078–82.PubMedGoogle Scholar
  11. Centers for Disease Control and Prevention. Comprehensive procedures for collecting environmental samples for culturing Bacillus anthracis (revised April 2002). Accessed March 2003. Available from URL: http://www.bt.cdc.gov/agent/anthrax/environmental-sampling-apr2002.asp
  12. Teshale  EH, Painter  J, Burr  GA, Mead  P, Wright  SV, Cseh  LF, Environmental sampling for spores of Bacillus anthracis. Emerg Infect Dis. 2002;8:1083–7.PubMedGoogle Scholar
  13. Centers for Disease Control and Prevention. Evaluation of Bacillus anthracis contamination inside the Brentwood mail processing and distribution center—District of Columbia, October 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1129–33.
  14. Centers for Disease Control and Prevention, American Society of Microbiology, Association of Public Health Laboratories. Basic diagnostic testing protocols for level A laboratories for the presumptive identification of Bacillus anthracis. Accessed March 2003. Available from URL: http://www.bt.cdc.gov/agent/anthrax/LevelAProtocol/ban-la-cp-031802.pdf
  15. Jernigan  DB, Raghunathan  PL, Bell  BP, Brechner  R, Bresnitz  EA, Butler  JC, Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019–28.PubMedGoogle Scholar
  16. Traeger  MS, Wiersma  ST, Rosenstein  NE, Malecki  JM, Shepard  CW, Raghunathan  PL, First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach, Florida, 2001. Emerg Infect Dis. 2002;8:1029–34.PubMedGoogle Scholar
  17. Hsu  VP, Lukacs  SL, Handzel  T, Hayslett  J, Harper  S, Hales  T, Opening a Bacillus anthracis–containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis. 2002;8:1039–44.PubMedGoogle Scholar
  18. Ingelsby  TV, O’Toole  T, Henderson  DA, Bartlett  JG, Ascher  MS, Eitzen  E, Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236–52. DOIPubMedGoogle Scholar
  19. Gleiser  CA, Berdjis  CC, Hartman  HA, Gochenour  WS. Pathology of experimental respiratory anthrax in Macaca mulatta. Br J Exp Pathol. 1963;44:416–26.PubMedGoogle Scholar
  20. Webb  GF, Blaser  MJ. Mailborne transmission of anthrax: modeling and implications. Proc Natl Acad Sci U S A. 2002;99:7027–32. DOIPubMedGoogle Scholar
  21. Holtz  TH, Ackelsburg  JA, Kool  J, Rosselli  R, Marfin  A, Matte  T, Isolated case of inhalational anthrax due to intentional contamination, New York City, 2001. Emerg Infect Dis. 2003; 9.

Main Article

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external